Verano Holdings Corp (VRNO) is a drug manufacturers - specialty & generic company listed on OTCQX.
Latest reported VRNO revenue for 2025-12-31 was $821.5M. Net income was -$257.9M. Revenue was down 6.5% from 2024-12-31 to 2025-12-31. VRNO currently screens at market cap $432.4M.
Use this VRNO page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the VRNO quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the VRNO SEC filings page. Lician reads the product cache first so this HTML stays unique to Verano Holdings Corp even when a live quote feed is slow.
Latest cached year on this hub. Full VRNO income, balance, and cash tables.